• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素衍生物作为HIV-1整合酶抑制剂的定量构效关系研究。

QSAR study of curcumine derivatives as HIV-1 integrase inhibitors.

作者信息

Gupta Pawan, Sharma Anju, Garg Prabha, Roy Nilanjan

机构信息

Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab, India.

出版信息

Curr Comput Aided Drug Des. 2013 Mar;9(1):141-50.

PMID:23286784
Abstract

A QSAR study was performed on curcumine derivatives as HIV-1 integrase inhibitors using multiple linear regression. The statistically significant model was developed with squared correlation coefficients (r(2)) 0.891 and cross validated r(2) (r(2) cv) 0.825. The developed model revealed that electronic, shape, size, geometry, substitution's information and hydrophilicity were important atomic properties for determining the inhibitory activity of these molecules. The model was also tested successfully for external validation (r(2) pred = 0.849) as well as Tropsha's test for model predictability. Furthermore, the domain analysis was carried out to evaluate the prediction reliability of external set molecules. The model was statistically robust and had good predictive power which can be successfully utilized for screening of new molecules.

摘要

使用多元线性回归对姜黄素衍生物作为HIV-1整合酶抑制剂进行了定量构效关系(QSAR)研究。构建了具有统计学意义的模型,其平方相关系数(r(2))为0.891,交叉验证r(2)(r(2) cv)为0.825。所构建的模型表明,电子性质、形状、大小、几何结构、取代基信息和亲水性是决定这些分子抑制活性的重要原子性质。该模型还成功通过外部验证(r(2) pred = 0.849)以及用于模型可预测性的Tropsha检验。此外,进行了域分析以评估外部数据集分子的预测可靠性。该模型具有统计学稳健性和良好的预测能力,可成功用于筛选新分子。

相似文献

1
QSAR study of curcumine derivatives as HIV-1 integrase inhibitors.姜黄素衍生物作为HIV-1整合酶抑制剂的定量构效关系研究。
Curr Comput Aided Drug Des. 2013 Mar;9(1):141-50.
2
Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.基于形状的筛选、QSAR 和对接方法鉴定新型 HIV-1 整合酶抑制剂。
Chem Biol Drug Des. 2012 May;79(5):835-49. doi: 10.1111/j.1747-0285.2012.01326.x. Epub 2012 Feb 9.
3
Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors.姜黄素衍生物作为 HIV-1 整合酶抑制剂的比较对接和 CoMFA 分析。
Mol Divers. 2011 Aug;15(3):733-50. doi: 10.1007/s11030-011-9304-7. Epub 2011 Feb 15.
4
Docking-based 3D-QSAR study of HIV-1 integrase inhibitors.基于对接的 HIV-1 整合酶抑制剂的 3D-QSAR 研究。
Eur J Med Chem. 2009 Nov;44(11):4276-87. doi: 10.1016/j.ejmech.2009.07.010. Epub 2009 Jul 16.
5
QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.QSAR 研究羧酸衍生物作为 HIV-1 整合酶抑制剂。
Eur J Med Chem. 2010 Sep;45(9):3970-80. doi: 10.1016/j.ejmech.2010.05.052. Epub 2010 Jun 1.
6
Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.4,5-二羟基嘧啶羧酰胺作为HIV-1整合酶抑制剂的多变量定量构效关系研究
Eur J Med Chem. 2009 Sep;44(9):3577-83. doi: 10.1016/j.ejmech.2009.03.001. Epub 2009 Mar 9.
7
3D-QSAR studies of quinoline ring derivatives as HIV-1 integrase inhibitors.3D-QSAR 研究作为 HIV-1 整合酶抑制剂的喹啉环衍生物。
SAR QSAR Environ Res. 2012 Oct;23(7-8):683-703. doi: 10.1080/1062936X.2012.717541. Epub 2012 Sep 20.
8
Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.抑制HIV整合酶的结构要求研究:定量构效关系研究
Acta Pharm. 2009 Mar;59(1):31-43. doi: 10.2478/v10007-009-0006-y.
9
Diverse models for the prediction of HIV integrase inhibitory activity of substituted quinolone carboxylic acids.取代喹诺酮羧酸类化合物抑制 HIV 整合酶活性的多种预测模型。
Arch Pharm (Weinheim). 2012 Dec;345(12):989-1000. doi: 10.1002/ardp.201100316. Epub 2012 Sep 4.
10
Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.设计 2-吡咯烷酮类化合物作为 HIV-1 整合酶抑制剂。
Bioorg Med Chem Lett. 2011 Nov 15;21(22):6724-7. doi: 10.1016/j.bmcl.2011.09.054. Epub 2011 Sep 20.

引用本文的文献

1
A computational overview of integrase strand transfer inhibitors (INSTIs) against emerging and evolving drug-resistant HIV-1 integrase mutants.整合酶抑制剂(INSTIs)抗新兴和不断进化的耐药性 HIV-1 整合酶突变体的计算概述。
Arch Microbiol. 2023 Mar 26;205(4):142. doi: 10.1007/s00203-023-03461-8.
2
Rational Computational Approaches in Drug Discovery: Potential Inhibitors for Allosteric Regulation of Mutant Isocitrate Dehydrogenase-1 Enzyme in Cancers.理性计算方法在药物发现中的应用:用于癌症中突变型异柠檬酸脱氢酶-1 酶变构调节的潜在抑制剂。
Molecules. 2023 Mar 2;28(5):2315. doi: 10.3390/molecules28052315.
3
Bioactive Effects of Curcumin in Human Immunodeficiency Virus Infection Along with the Most Effective Isolation Techniques and Type of Nanoformulations.
姜黄素在人类免疫缺陷病毒感染中的生物活性作用及其最有效的分离技术和纳米制剂类型。
Int J Nanomedicine. 2022 Aug 15;17:3619-3632. doi: 10.2147/IJN.S364501. eCollection 2022.
4
HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors.HIVprotI:一个基于网络的用于预测和设计HIV蛋白质抑制剂的综合平台。
J Cheminform. 2018 Mar 9;10(1):12. doi: 10.1186/s13321-018-0266-y.
5
Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability.乳腺癌耐药蛋白(BCRP)作为主动外排转运体在血脑屏障(BBB)通透性方面的作用。
Mol Divers. 2015 Feb;19(1):163-72. doi: 10.1007/s11030-014-9562-2. Epub 2014 Dec 14.